Evaluation of cerebral dysfunction in patients with chronic kidney disease using neuropsychometric and neurophysiological tests
Autor: | Fabiola Sanchez-Meza, Aldo Torre, Lilia Castillo-Martinez, Sofia Sanchez-Roman, Luis Eduardo Morales-Buenrostro |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: | |
Zdroj: | Renal Failure, Vol 43, Iss 1, Pp 577-584 (2021) |
Druh dokumentu: | article |
ISSN: | 0886-022X 1525-6049 0886022X 84236191 |
DOI: | 10.1080/0886022X.2021.1901740 |
Popis: | Background Uremic encephalopathy is defined as cerebral dysfunction due to toxin accumulation in patients with chronic kidney disease (CKD). This condition is characterized by subtle to florid symptoms, and its clinical course is always progressive when untreated but partially reversible with renal replacement therapy. While no test exists to measure subclinical uremic encephalopathy, two tests have been validated to measure minimal hepatic encephalopathy: the critical flicker frequency (CFF) test and the psychometric hepatic encephalopathy score (PHES). Objective To use CFF and PHES to measure the prevalence of cerebral dysfunction in individuals with CKD. Methods This cross-sectional study included a total of 69 patients with stage-5 CKD. Cutoff points for minimal encephalopathy were established using existing clinical guidelines: ≤39 Hz for CFF and |
Databáze: | Directory of Open Access Journals |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |